CALVIN SANDRA (VP, Corp Controller and CAO) sold 8.1% of their position (4.33K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $139.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2026ACC: 0001882909-26-000001
Officer· VP, Corp Controller and CAO
Since Sep 2021
+31.01K
Net shares
Net buyer
$139.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
35.34K acquired · 4.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.18K
Price / share
—
Trade value
—
% of position
39.7%
1/31/2026
38.23K→53.41K
Common Stock
Direct
Shares
−4.33K
Price / share
$32.12
Trade value
$139.18K
% of position
8.1%
2/3/2026
53.41K→49.08K
Total
Net shares
+10.85K
Net value
-$139.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | A · Award | +15.18K | — | — | 39.7% | 38.23K | 53.41K |
| Common Stock Direct | 2/3/2026 | S · Sale | −4.33K | $32.12 | $139.18K | 8.1% | 53.41K | 49.08K |
| Total | +10.85K | -$139.18K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
20.16K shares
Shares
+20.16K
Strike price
33.095
Held after
20.16K
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock20.16K shares | 1/31/2026 | A · Award | +20.16K | 33.095 | — | 20.16K |